Cancer Therapy Resistance: Choosing Kinase Inhibitors-Reference-Cited by-同舟云学术

Cancer Therapy Resistance: Choosing Kinase Inhibitors

Published:2024-03-07 Issue:3 Volume:16 Page:373
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Dell’Aversana Carmela¹²^ORCID,Sarno Federica²³^ORCID,Benedetti Rosaria²^ORCID,Megchelenbrink Wouter Leonard²⁴,Cappetta Donato⁵

Affiliation:

1. Institute of Experimental Endocrinology and Oncology “Gaetano Salvatore” (IEOS)-National Research Council (CNR), 80131 Napoli, Italy

2. Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy

3. Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands

4. Prinses Máxima Centrum for Pediatric Oncology, 3584 CS Utrecht, The Netherlands

5. Division of Pharmacology, Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy

Abstract

Recent advances in comprehending the essential molecular mechanisms that govern cancer signaling have revealed the pivotal involvement of kinases in the development and progression of various cancer types [...]

Funder

Ministry of Education, Universities and Research

Publisher

MDPI AG

Link

https://www.mdpi.com/1999-4923/16/3/373/pdf

Reference20 articles.

1. Acquired Resistance to Drugs Targeting Tyrosine Kinases;Rosenzweig;Adv. Cancer Res.,2018

2. Endocrine therapy resistance: What we know and future directions;Musheyev;Explor. Target. Antitumor Ther.,2022

3. Kinase-targeted cancer therapies: Progress, challenges and future directions;Bhullar;Mol. Cancer,2018

4. Kinase drug discovery 20 years after imatinib: Progress and future directions;Cohen;Nat. Rev. Drug Discov.,2021

5. New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome;Wilson;Cancer Res.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death;Bioorganic & Medicinal Chemistry;2024-09

2. Editorial: Protein kinase inhibitors in neurodegeneration and cancer targeted therapies;Frontiers in Cell and Developmental Biology;2024-04-18